Methicillin resistant staphylococcus aureus| Coherent Market Insights

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) TESTING SYSTEMS MARKET ANALYSIS Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product (Instruments, Reagents & Kits),By Test Type (Immunodiagnostic Test and Molecular Diagnostic Test),By End User (Hospitals, Diagnostic Laboratories, and Academic and Research Institute) and By Region (North America,Latin America, Europe,Asia Pacific,Middle East and Africa) - Size, Share,Outlook, and Opportunity Analysis, 2020 - 2027

3. The Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems market is estimated to be valued at US$ 105.08 million in 2020 and is expected to exhibit a CAGR of 10.5% during the forecast period (2020-2027). Market Growth • The growing prevalence of methicillin resistant Staphylococcus aureus infection worldwide is expected to drive growth of the methicillin resistant Staphylococcus aureus (MRSA) testing systems market. According to the U.S. Department of Health and Human Services report of March 2019, nearly 120,000 staphylococcus aureus bloodstream infections and 20,000 associated deaths occurred in the U.S. in 2017. After years of slow progress, the rate of decline of MRSA bloodstream infections has slowed, but bloodstream infections caused by methicillin-susceptible S. aureus in hospitals are increasing day by day in the community.

4. Moreover, products approvals by regulatory bodies are expected to accelerate the Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems market growth in the near future. For instance, in October 2019, Luminex Corporation announced that the company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ARIES MRSA Assay. The assay is an integrated, real-time, polymerase chain reaction (PCR) based, qualitative, in vitro diagnostic test for the direct detection of methicillin-resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization. The Luminex ARIES System is a real-time instrument designed to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into the modern laboratory.

5. Figure 1.Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market Share (%) Analysis,By Product, 2020

6. Market Restraints However, growth of the methicillin resistant staphylococcus aureus (MRSA) testing systems market may be hampered owing to the increasing product recalls of methicillin resistant staphylococcus aureus (MRSA) testing systems in the market.For instance,in August 2019,the U.S. FDA initiated a product recall on Becton Dickinson & Company’s BD Max MRSA test kit because the foil bags containing extraction tubes for BD MAX Reagent products may not be sealed properly which can lead to false representation of test results.An advisory has been released to all the users of BD Max instruments within testing facilities to ensure awareness and prevent false test results.

7. Regional Analysis • North America accounted for the largest share in the methicillin resistant staphylococcus aureus (MRSA) testing systems market,in 2019 owing to the increasing number of mergers and acquisitions in the U.S. For instance,in April 2017,Avantor Performance Materials,LLC,announced the acquisition of Puritan Products,Inc.,a supplier of cGMP buffers and solutions for Biopharma customers and high-purity chemistries for Research and Electronic Materials customers.The acquisition of the Puritan Products brand expanded Avantor’s cGMP operations,improved supply chain security and provided new teams experienced in high purity materials manufacturing such as J.T.Baker,Macron Fine Chemicals, Puritan MRSA Transport Medium and Puritan brands of high-purity products and packaging for Avantor to become more agile and responsive to the needs of its customers.

8. Furthermore, major companies in the market are focusing on obtaining product approvals to gain commercial rights for the sale of their products in a particular country. This is expected to drive growth of the methicillin resistant staphylococcus aureus (MRSA) testing systems market in Europe. For instance, in January 2014, Roche announced the CE-IVD launch of the cobas MRSA/SA Test for the early, simultaneous detection of methicillin-resistant staphylococcus aureus (MRSA) and methicillin-sensitive staphylococcus aureus (SA) from nasal specimens. The cobas MRSA/SA test detects both organisms from a single specimen, providing accurate and reliable results for effective prevention and control of MRSA/SA infections. With an innovative design to include diverse geographical strain coverage, coupled with automation on the cobas 4800 System, the cobas MRSA/SA test can process specimens using a fast and advanced real-time polymerase chain reaction (PCR) amplification and detection available.

9. Fig.2Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market Value (US$ Mn) & Y-o-Y Growth (%),2017-2027

10. Competitive Section Key players operating in the methicillin resistant Staphylococcus aureus (MRSA) testing systems market are F.Hoffmann-La Roche, Becton, Dickinson and Company, Hain Lifescience GmbH, BioMérieux, 3M Company, Bio-Rad Laboratories Inc., Abacus Diagnostica, Abbott Laboratories, Puritan Medical Products, Diatherix Eurofins, LLC, Arlington Scientific Inc., AdvanDx, Genspeed Biotech GmbH, Cepheid Inc., Luminex Corporation, and R-Biopharm AG

11. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst Reference: https://www.coherentmarketinsights.com/market-insight/methicillin-resistant-staphylococcus-aureus-testing-systems-market-3803

12. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

13. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

14. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/